Hy-Tech Engineers leads IPO grey market premium race against peers

Three companies preparing for market debuts are drawing divergent investor interest based on grey market premium (GMP) indicators and subscription metrics, with Hy-Tech Engineers emerging as the frontrunner in anticipated listing gains. The engineering firm is signalling stronger grey market sentiment compared to pharmaceutical company Symbiotec Pharmalab and airline operator Skyways Air, according to latest GMP tracking across market channels. Grey market premiums serve as informal barometers of investor demand before formal listing, reflecting expected price movements on debut trading. Hy-Tech Engineers' stronger GMP reflects robust subscription demand during its offer period, suggesting retail and institutional investors are pricing in anticipated listing gains above the issue price. Symbiotec Pharmalab and Skyways Air, while drawing investor participation, are tracking comparatively lower grey market valuations at present. Market participants cautioned that grey market indicators, while informative, do not guarantee listing performance as actual debut prices depend on market conditions, final share allocation and opening day trading dynamics. Investors tracking these debuts should monitor final subscription figures and official allotment results for clearer signals on anticipated listing performance.